WuXi Global Forum 2017 and Reception – A Celebration of Global Partnerships

WuXi Global Forum 2017 and Reception – A Celebration of Global Partnerships

By WuXi AppTec

Date and time

Tuesday, January 10, 2017 · 2 - 7pm PST

Location

Grand Hyatt San Francisco Grand Ballroom

345 Stockton Street San Francisco, CA 94108

Description

Thank you for your interest in the WuXi Global Forum 2017. We have met our maximum capacity for this event. Registration is now closed.

Brought to you by WuXi AppTec, BayHelix, BioCentury Inc., Biocom, BioWorld Today, ChinaBio, SVIEF, QB3, WuXi Healthcare Ventures, and Informa, this invitation-only and complimentary annual global forum, now in its fifth year, brings together 1,000 industry leaders to promote new thinking on a global stage as we strive to find transformative models and solutions for patients, at a time when stakes are higher than ever for our industry.

Click here to view the 2017 WuXi Global Forum Program

Announcing Distinguished Speakers for WuXi Global Forum at J.P. Morgan Healthcare Conference:

  • Ge Li, Founder, Chairman and CEO, WuXi AppTec

  • David Flores, President and CEO, BioCentury

  • Ryan Watts, CEO, Denali Therapeutics

  • Keith Leonard, CEO, Unity Biotechnology

  • Yujiro Hata, Co-Founder and CEO, IDEAYA Biosciences

  • Edward Hu, CFO and CIO, WuXi AppTec

  • Alexis Borisy, Partner, Third Rock Ventures

  • Shoucheng Zhang, Professor at Stanford University; Chairman, Danhua Capital

  • Yibing Wu, Joint Head of Portfolio Strategy & Risk Group and Joint Head of China, Temasek

  • Gregory Verdine, Erving Professor of Chemistry, Harvard University; CEO, FogPharma and LifeMine; Partner, WuXi Healthcare Ventures

  • John Reed, Head of Pharma Research and Early Development (pRED), Roche

  • Peter Schultz, CEO, The Scripps Research Institute and Calibr

  • Ken Drazan, Chief Business Officer, GRAIL

  • William Morice, Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic; President, Mayo Medical Laboratories

  • Chad Robins, President and CEO, Adaptive Biotechnologies

  • Steve Yang, EVP and COO, WuXi AppTec

  • Lonnie Moulder, CEO, TESARO

  • Michael Yu, President and CEO, Innovent Biologics

  • Li Chen, CEO and Co-Founder, Hua Medicine

  • Mike Ward, Global Director of Content, Informa Pharma Insight

  • Sara Radcliffe, President and CEO, California Life Sciences Association

  • Hui Cai, VP of Corporate Alliances and Head of Communications, WuXi AppTec



Organized by

WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the third consecutive year in 2023 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."

Sales Ended